Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study

• Status: Unknown status
• Trial end date: 2012-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to determine whether a pre-treatment with high-dose statin (one day prior and just before intervention, rosuvastatin 20mg/day) has a positive impact on the occurrence of periprocedural myocardial infarction during percutaneous coronary intervention (PCI).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Motol
• Treatments: Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• significant coronary artery stenosis or occlusion indicated for percutaneous coronary intervention

• signed informed consent

Exclusion Criteria:

• positive troponin I (≥ 1 ULN)

• previous inclusion in this study

• renal insufficiency (creatinine ≥ 200 umol/l)

• chronic treatment with rosuvastatin 40mg or more